NCT07534943

Brief Summary

The objective of this study is to investigate "clinically" the effectiveness of Oleanolic acid based intracanal medicament compared to the commonly used intracanal medicaments (Calcium hydroxide and Ledermix) on the levels of bacteria in root canals and inflammatory cytokines in the periradicular tissues of teeth with apical periodontitis.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
36

participants targeted

Target at P25-P50 for not_applicable

Timeline
1mo left

Started Mar 2026

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress51%
Mar 2026Jun 2026

Study Start

First participant enrolled

March 1, 2026

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

April 3, 2026

Completed
13 days until next milestone

First Posted

Study publicly available on registry

April 16, 2026

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2026

Last Updated

April 16, 2026

Status Verified

April 1, 2026

Enrollment Period

3 months

First QC Date

April 3, 2026

Last Update Submit

April 11, 2026

Conditions

Keywords

Intracanal medicamentsEndodontic infectionsInflammatory cytokines

Outcome Measures

Primary Outcomes (3)

  • Relief of signs and symptoms of apical periodontitis

    Absence of discomfort with percussion, Absence of inflammatory exudate from the root canal.

    1 Week

  • Decrease in bacterial count within the root canal.

    A sample will be taken from the canal to assess the decrease in bacterial count inside the root canal by the effect of intracanal medicament.

    1 week

  • Decrease in interleukin TNF-alpha, IL-1 Beta and PG-E2 in the periapical tissues

    A sample will be taken from the periapical region to detect the effect of the intracanal medicaments in reducing inflammation and promoting healing in the periapical region.

    1 week

Study Arms (3)

Calcium hydroxide group

EXPERIMENTAL

After biomechanical preparation of the canals, calcium hydroxide intracanal medicament will be placed inside the canal for one week before obturation.

Procedure: Root canal treatment

Ledermix group

EXPERIMENTAL

After biomechanical preparation of the canals, Ledermix intracanal medicament will be placed inside the canal for one week before obturation.

Procedure: Root canal treatment

Oleanolic acid group

EXPERIMENTAL

After biomechanical preparation of the canals, Oleanolic acid intracanal medicament will be placed inside the canal for one week before obturation.

Procedure: Root canal treatment

Interventions

Root canal treatments with administration of intracanal medicaments

Calcium hydroxide groupLedermix groupOleanolic acid group

Eligibility Criteria

Age20 Years - 60 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Single rooted teeth with pulp necrosis and apical periodontitis.
  • The age ranges from 20 to 60 years.

You may not qualify if:

  • Patient receiving antibiotic treatment within the preceding 3 months.
  • Patient reporting systemic disease.
  • Teeth that can not be isolated with rubber dam.
  • Teeth with periodontal pockets deeper than 3 mm.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Mansoura University

Al Mansurah, Dakahlia Governorate, 35511, Egypt

Location

Related Links

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 3, 2026

First Posted

April 16, 2026

Study Start

March 1, 2026

Primary Completion (Estimated)

June 1, 2026

Study Completion (Estimated)

June 1, 2026

Last Updated

April 16, 2026

Record last verified: 2026-04

Locations